指南与共识甲状腺与浅表头颈US

甲状腺结节恶性风险分层与细针穿刺推荐:ACR TI-RADS、AACE/ACE/AME与ATA指南的比较

Malignancy risk stratification and FNA recommendations for thyroid nodules: A comparison of ACR TI-RADS, AACE/ACE/AME and ATA guidelines.
指南 / 共识 · Am J Otolaryngol · 2020-06-24

回顾性纳入2015年10月至2016年3月230例患者共230个连续甲状腺结节(恶性137个、良性93个),由一名初级和一名高级放射科医师分别按ACR TI-RADS、AACE/ACE/AME和ATA指南分类。ACR TI-RADS诊断效能最高(初级医师AUC 0.815、高级医师AUC 0.864),敏感度也最高(初级86.1%、高级94.9%),推荐FNA的结节数最少(37.8%、40.4%)且其中恶性检出率最高(64.4%、68.8%)。

要点

  • ACR TI-RADS在初级和高级医师中AUC分别为0.815和0.864,为三种指南中最高。
  • ACR TI-RADS敏感度初级医师86.1%、高级医师94.9%,高于AACE/ACE/AME和ATA指南。
  • ATA指南有19.6%(45/230)结节不匹配任何模式,但其中恶性风险高达68.9%。

核心结论

  • ACR指南呈现更高的诊断指标水平,并可能显著减少FNA推荐数量且伴更高的恶性检出率。

研究设计与样本

  • 回顾性研究,经医院伦理委员会批准并豁免知情同意,纳入2015年10月至2016年3月230例患者的230个连续甲状腺结节。
  • 由一名初级和一名高级放射科医师分别按ACR TI-RADS、AACE/ACE/AME和ATA指南对每个结节分类,两两比较采用卡方检验。

关键影像表现/征象

  • 230个结节中恶性137个、良性93个。
  • ATA指南下有19.6%(45/230)的结节不匹配任何模式,但该组恶性风险为68.9%。

诊断标准与关键数值

  • ACR TI-RADS的AUC:初级医师0.815,高级医师0.864,为三种指南中最高。
  • ACR TI-RADS敏感度:初级医师86.1%,高级医师94.9%,高于AACE/ACE/AME和ATA指南。
  • ACR TI-RADS推荐FNA的结节比例最低:初级医师37.8%,高级医师40.4%。
  • ACR TI-RADS推荐FNA结节中的恶性检出率最高:初级医师64.4%,高级医师68.8%。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To compare diagnostic performance and malignancy risk stratification among guidelines set forth by the American Thyroid Association (ATA) in 2015, the American Association of Clinical Endocrinologists (AACE), the American College of Endocrinology (ACE) and the Association Medici Endocrinologi (AME) in 2016, and the American College of Radiology (ACR) in 2017.

METHODS: The retrospective study was approved by the hospital ethics committee, and the informed consent requirement was waived. From October 2015 to March 2016, a total of 230 patients with 230 consecutive thyroid nodules were enrolled in this study. Each nodule was classified by one junior and one senior radiologist separately according to ACR TI-RADS, AACE/ACE/AME and ATA guidelines. The malignancy diagnostic performance and the number of FNA recommendations were pairwise compared among three guidelines using chi-square tests.

RESULTS: Of the 230 thyroid nodules, 137 were malignant, and 93 were benign. However, 19.6% of the nodules (45 of 230) did not match any pattern using the ATA guidelines but with a high risk of malignancy (68.9%). The ACR TI-RADS derived the highest diagnostic performance, from both junior radiologist (AUC 0.815) and senior radiologist (AUC 0.864). The ACR guidelines also showed the greatest level of sensitivity (junior: 86.1%, senior: 94.9%), compared with AACE/ACE/AME and ATA guidelines. The number of thyroid nodules recommended to fine-needle aspiration (FNA) was the lowest (37.8%, 40.4%) by ACR TI-RADS, and meanwhile, the malignant detection rate within these nodules was highest (64.4%, 68.8%).

CONCLUSIONS: The ACR guidelines present a higher level of diagnostic indicators and may offer a meaningful reduction in FNA recommendations with a higher malignancy detection rate.

来源:Am J Otolaryngol,查看原文。版权归原作者所有。

引用

  1. Peng JY, Pan FS, Wang W, et al. Malignancy risk stratification and FNA recommendations for thyroid nodules: A comparison of ACR TI-RADS, AACE/ACE/AME and ATA guidelines. Am J Otolaryngol. 2020. PMID: 32668355. doi:10.1016/j.amjoto.2020.102625

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。